中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Propofol and Dexmedetomidine on Inflammation

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态
赞助商
The First Affiliated Hospital of Anhui Medical University

关键词

抽象

Dexmedetomidine, was reported to prevent postoperative delirium in elderly patients following its use in intensive care units. Possible mechanisms included improved quality of sleep and an inhibitory effect on inflammation. A greater number of studies indicated that propofol has negative effect on postoperative cognitive function. In this study, we planned to investigate the influence of these two different sedative drugs on peripheral inflammation induced by surgery and postoperative cognitive function of patients who will receive hip and knee arthroplasty.

描述

Dexmedetomidine, was reported to prevent postoperative delirium in elderly patients following its use in intensive care units. Possible mechanisms included improved quality of sleep and an inhibitory effect on inflammation. A greater number of studies indicated that propofol has negative effect on postoperative cognitive function. In this study, patients who will receive hip and knee arthroplasty will be divided to two groups: Propofol group and Dexmedetomidine group. Spinal anesthesia will be used to meet the requirement of intraoperative analgesia. Patients in two groups will be sedated by propofol and dexmedetomidine, respectively. TNF-α and IL-6 in blood will be detected. And postoperative cognitive function of patients will be investigated. The objective of this study is to clarify the influence of these two different sedative drugs on peripheral inflammation induced by surgery, and the relationship with the change of postoperative cognitive function.

日期

最后验证: 03/31/2018
首次提交: 06/26/2018
提交的预估入学人数: 07/15/2018
首次发布: 07/25/2018
上次提交的更新: 07/15/2018
最近更新发布: 07/25/2018
实际学习开始日期: 07/31/2018
预计主要完成日期: 08/31/2018
预计完成日期: 11/30/2018

状况或疾病

Inflammation
Postoperative Delirium
Anesthesia

干预/治疗

Drug: Propofol group

Drug: Dexmedetomidine group

-

手臂组

干预/治疗
Experimental: Propofol group
Patients in this arm will be sedated by propofol.
Drug: Propofol group
Propofol will be used to offer intraoperative sedation for patients in Propofol group.
Experimental: Dexmedetomidine group
Patients in this arm will be sedated by dexmedetomidine.
Drug: Dexmedetomidine group
Dexmedetomidine will be used to offer intraoperative sedation for patients in Dexmedetomidine group.

资格标准

有资格学习的年龄 65 Years 至 65 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- The patients included in this study were 65 years or older, were undergoing total hip arthroplasty, and were classified as American Society of Anesthesiologists (ASA) physical health class I-IV.

Exclusion Criteria:

- Contraindications to spinal anesthesia (i.e., coagulopathy, concurrent use of anticoagulants, infection at puncture site, and refusal of spinal anesthesia), patients with infectious diseases, patients with mental or language barriers, patients who had been anesthetized within the past 30 days, severe congestive heart failure (New York Heart Association, class IV) and/or severe chronic obstructive pulmonary disease (Global Initiative for Chronic Obstructive Lung Disease Guidelines, stages III-IV), sick sinus syndrome, severe sinus bradycardia (< 50 beats per min), and second or greater atrioventricular block without pacemaker. In addition, patients exhibiting cognitive impairment (i.e., a Mini-Mental State Examination (MMSE) score < 24) and/or preoperative delirium (i.e., positive Confusion Assessment Method (CAM) result) were excluded.

结果

主要结果指标

1. change of the concentration of IL-6 [Preoperative and end of surgery]

Change of the concentration of plasma IL-6 from baseline to the end surgery

次要成果指标

1. Postoperative delirium [Postoperative (1-3 days after surgery)]

The incidence of postoperative delirium

2. Postoperative cognitive dysfunction [Postoperative (7 and 30 days after surgery)]

The incidence of postoperative cognitive dysfunction

3. change of the concentration of TNF-α [Preoperative and end of surgery]

Change of the concentration of plasma TNF-α from baseline to the end surgery

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge